1. Home
  2. BYSI

as 05-30-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

Founded: 2010 Country:
United States
United States
Employees: N/A City: FLORHAM PARK
Market Cap: 67.3M IPO Year: 2017
Target Price: N/A AVG Volume (30 days): 20.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.09 EPS Growth: N/A
52 Week Low/High: $0.98 - $2.97 Next Earning Date: 05-12-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

BYSI Daily Stock ML Predictions

Share on Social Networks: